Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

Customs and Border Protection officers will continue to work with the trade industry and our consumer safety partners to ...

During a routine check on October 5, CBP seized a shipment declared as a "cosmetic weight loss product" only to find it ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

Lou Scofield weighed her heaviest in 2023 at 17.5st and wore a size 20 clothes due to being perimenopausal and comfort eating ...

The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products, such as Ozempic, on the local ...

A SCOTS nurse is thought to be the first person to die in the UK after taking a weight loss injection recently approved by ...

The various trials covered time periods ranging from 40 to 52 weeks and included three different strengths of Mounjaro: 5 mg, 10 mg, and 15 mg. The primary endpoint for all the SURPASS trials was ...